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Background
Noninvasive detection of myocarditis is a unique feature of
Cardiovascular Magnetic Resonance (CMR), but conven-
tional CMR-imaging suffers from different challenges
including imaging quality. It has already been shown, that
T1 mapping has the potential to identify acute myocarditis
[1,2].
We aim to differentiate the course of disease and to
identify the acute stage by combining mapping techniques.
Methods
Eighteen patients with clinically defined acute myocarditis
were prospectively examined three times during follow up
using a 1.5 T Scanner (FU0: within 2 weeks of symptoms
onset, FU1: 5 weeks FU2: after 6 months). They were com-
pared to a healthy sex- and age matched control group.
Severity of disease was rated in NYHA and CCS score.
Left ventricular (LV) volumes, mass and function were
assessed using steady-state free precession (SSFP) cine
imaging in short axis. Parametric mapping was applied
using T2 maps in three short axis (TE 1.15 ms, ST 6 mm,
SSFP) and native T1 mapping using modified look-locker
inversion recovery (MOLLI 5(3)5) sequence (TE 1.11 ms,
ST 6 mm) in a basal and a midventricular slice. Further-
more, T1 mapping was performed during contrast media
wash-out (Gadobutrol 0.15 mmol/kgBW) at minute
1,3,5,7,10. Late gadolinium enhancement (LGE) was per-
formed after minute 12 for myocardial fibrosis detection.
Blood collection was done for haematocrit assessment.
Data were analyzed using CVI42 (circle cardiovascular
imaging Inc., Calgary, Canada), Mann-Whitney U test was
used.
Results
All 18 patients and healthy volunteers completed all exam-
inations (age 30.06 ± 10.9 vs. 29.72 ± 9.93 years, 14 male
and 4 female, respectively). NYHA score decreased from
1.8 ± 0.95 (FU0) to 0.5 ± 0.5 (FU2), CCS score decreased
from 2.3 (FU0) to 0.3 (FU2).
14(78%) patients showed focal fibrosis (LGE pos).
Global T2 relaxation times decreased during follow up
(p < 0.001 from FU0 to FU2). ROC analysis revealed a
area under the curve of 0.9 for cutoff 51.92 ms (sensitivity
89%, specifity 83%) to differentiate diseased from healthy
volunteers. Global native T1 remains stable (FU0 to FU2,
p = 0.311), however, native T1 was significantly higher in
patients than in healthy volunteers (p=0.003). Difference
in T1 during contrast media washout between patients
and healthy volunteers was significant at minute 3 at FU0
(321 ± 37 ms vs. 361 ± 31 ms, p = 0.001). Global ECV was
increased at FU0 (p=0.021) and normalized at FU2
(p=0.164) compared to control group. See table 1 for
details.
Conclusions
T1 mapping allows the identification of diseased in com-
parison to healthy volunteers. Additional use of T2 map-
ping enables to detect disease acuity and so far to identify
reversibility. Further follow up examinations would be
necessary to identify its prognostic values. Parametric
mapping may replace parts of conventional imaging
techniques.
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Table 1 Time course of LV ejection fraction and parametric mapping during follow up compared to healthy control
group
FU 0 acute phase FU1 5 weeks FU2 6 months Healthy control group
ejection fraction (%) 58.5 ± 6.7 (p=0.133) 60.37 ± 6.1 (p=0.548) 60.03 ± 4.4 (p=0.658) 61.32 ± 3.7
Global T2 time (ms) 55.1 ± 2,6 (p < 0.001) 52.2 ± 1.4 (p=0.012) 51.2 ± 2 (p=0.429) 50.6 ± 1.9
Native T1 time (ms) 1015 ± 36 (p=0.003) 1003 ± 27 (p=0.015) 1001 ± 31 (p=0.043) 978 ± 32
Global ECV 0.259 ± 0.02 (p=0.021) 0.258 ± 0.02 (p=0.019) 0.256 ± 0.03 (p=0.164) 0.243 ± 0.02
Figure 1 Segmental T1, T2 times and ECV. Red numbers mean that p < 0.05 compared to control group.
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